NO770547L - Analogifremgangsm}te for fremstilling av farmakologisk aktive indolizinderivater. - Google Patents

Analogifremgangsm}te for fremstilling av farmakologisk aktive indolizinderivater.

Info

Publication number
NO770547L
NO770547L NO770547A NO770547A NO770547L NO 770547 L NO770547 L NO 770547L NO 770547 A NO770547 A NO 770547A NO 770547 A NO770547 A NO 770547A NO 770547 L NO770547 L NO 770547L
Authority
NO
Norway
Prior art keywords
preparation
pharmacologically active
indolizine derivatives
analogical procedure
analogical
Prior art date
Application number
NO770547A
Other languages
English (en)
Other versions
NO145842C (no
NO145842B (no
Inventor
Jean Gubin
Gilbert Rosseels
Original Assignee
Labaz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB6680/76A external-priority patent/GB1518443A/en
Application filed by Labaz filed Critical Labaz
Publication of NO770547L publication Critical patent/NO770547L/no
Publication of NO145842B publication Critical patent/NO145842B/no
Publication of NO145842C publication Critical patent/NO145842C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/16—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
    • C07D213/20—Quaternary compounds thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
NO770547A 1976-02-19 1977-02-18 Analogifremgangsmaate for fremstilling av farmakologisk aktive indolizinderivater NO145842C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB6680/76A GB1518443A (en) 1976-02-19 1976-02-19 Indolizine derivatives and process for preparing the same
GB3331476 1976-08-10

Publications (3)

Publication Number Publication Date
NO770547L true NO770547L (no) 1977-08-22
NO145842B NO145842B (no) 1982-03-01
NO145842C NO145842C (no) 1982-06-09

Family

ID=26240878

Family Applications (1)

Application Number Title Priority Date Filing Date
NO770547A NO145842C (no) 1976-02-19 1977-02-18 Analogifremgangsmaate for fremstilling av farmakologisk aktive indolizinderivater

Country Status (22)

Country Link
US (1) US4103012A (no)
JP (1) JPS52125193A (no)
AR (2) AR211887A1 (no)
AT (1) AT358035B (no)
AU (1) AU505894B2 (no)
CA (1) CA1071198A (no)
CH (2) CH617697A5 (no)
DE (1) DE2707048C2 (no)
DK (1) DK142622B (no)
ES (2) ES456039A1 (no)
FI (1) FI61030C (no)
FR (1) FR2341578A1 (no)
GR (1) GR59328B (no)
IE (1) IE44941B1 (no)
IT (1) IT1085862B (no)
NL (1) NL164283C (no)
NO (1) NO145842C (no)
NZ (1) NZ183377A (no)
OA (1) OA05575A (no)
PT (1) PT66199B (no)
SE (1) SE420314B (no)
YU (3) YU39489B (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ193926A (en) * 1979-07-06 1984-05-31 Labaz Sanofi Nv 2-(alkyl or phenyl)-3(4-hydroxybenzoyl)indolizines
US4378362A (en) * 1979-12-06 1983-03-29 S.A. Labaz N.V. Indolizine derivatives and process for preparing the same
FR2495616A1 (fr) * 1980-12-09 1982-06-11 Labaz Nv Nouveaux derives d'indolizine, leur procede de preparation ainsi que leurs applications en therapeutique
US4520026A (en) * 1981-02-06 1985-05-28 S. A. Labaz N.V. Indolizine derivatives and use as cardiovascular agents
FR2528845A1 (fr) * 1982-06-17 1983-12-23 Sanofi Sa Nouveaux derives d'indolizine, leur procede de preparation ainsi que les compositions therapeutiques les contenant
JPS59113802U (ja) * 1983-01-14 1984-08-01 オムロン株式会社 制御装置
US5215988A (en) * 1986-02-14 1993-06-01 Sanofi Aminoalkoxyphenyl derivatives, process of preparation and compositions containing the same
FR2594438B1 (fr) * 1986-02-14 1990-01-26 Labaz Sanofi Nv Derives d'indolizine, leur procede de preparation ainsi que les compositions en contenant
IL83821A0 (en) * 1986-09-10 1988-02-29 Sandoz Ag Azaindole and indolizine derivatives,their production and pharmaceutical compositions containing them
IL87181A (en) * 1987-08-07 1993-08-18 Sanofi Sa Aminoalkoxyphenyl derivatives, their preparation and pharmaceutical and veterinary compositions containing them
US4880824A (en) * 1987-09-21 1989-11-14 Ortho Pharmaceutical Corporation Phenyl and benzoyl substituted imidazo-fused heterocyclic calcium channel blockers
FR2642755B1 (no) * 1989-02-07 1993-11-05 Sanofi
FR2642756B1 (fr) * 1989-02-07 1994-03-04 Sanofi Derives cycloaminoalkoxyphenyle, leur procede de preparation ainsi que les compositions pharmaceutiques ou veterinaires en contenant
FR2665444B1 (fr) * 1990-08-06 1992-11-27 Sanofi Sa Derives d'amino-benzofuranne, benzothiophene ou indole, leur procede de preparation ainsi que les compositions les contenant.
FR2893616B1 (fr) * 2005-11-23 2008-01-04 Sanofi Aventis Sa Nouveaux derives d'indolizine, leur procede de preparation et les compositions therapeutiques les comprenant
FR2967412B1 (fr) 2010-11-17 2012-12-14 Sanofi Aventis Nouveaux derives d'indolizine, leur preparation et leur application en therapeutique
CN110283167A (zh) * 2018-11-14 2019-09-27 贵州省中国科学院天然产物化学重点实验室 一种抗心率失常药物布托普洛嗪的制备方法

Also Published As

Publication number Publication date
IT1085862B (it) 1985-05-28
AR211887A1 (es) 1978-03-31
IE44941B1 (en) 1982-05-19
FI61030C (fi) 1982-05-10
YU42791B (en) 1988-12-31
FI61030B (fi) 1982-01-29
ES456039A1 (es) 1978-05-16
NO145842C (no) 1982-06-09
NL164283C (nl) 1980-12-15
SE7701771L (sv) 1977-08-20
YU42888B (en) 1988-12-31
DK142622B (da) 1980-12-01
JPS5519234B2 (no) 1980-05-24
IE44941L (en) 1977-08-19
ATA92077A (de) 1980-01-15
AU505894B2 (en) 1979-12-06
YU39489B (en) 1984-12-31
CH623322A5 (no) 1981-05-29
OA05575A (fr) 1981-04-30
CH617697A5 (no) 1980-06-13
YU42877A (en) 1983-01-21
PT66199B (pt) 1978-07-12
SE420314B (sv) 1981-09-28
NL7701678A (nl) 1977-08-23
DK142622C (no) 1981-08-03
NO145842B (no) 1982-03-01
FR2341578A1 (fr) 1977-09-16
US4103012A (en) 1978-07-25
AU2239477A (en) 1978-08-24
FR2341578B1 (no) 1980-04-30
YU225183A (en) 1984-10-31
DK72677A (no) 1977-08-20
AR212791A1 (es) 1978-09-29
NZ183377A (en) 1980-04-28
ES467441A1 (es) 1978-10-16
FI770318A (no) 1977-08-20
DE2707048C2 (de) 1983-11-17
GR59328B (en) 1977-12-13
AT358035B (de) 1980-08-11
CA1071198A (en) 1980-02-05
JPS52125193A (en) 1977-10-20
DE2707048A1 (de) 1977-09-01
PT66199A (pt) 1977-03-01
NL164283B (nl) 1980-07-15

Similar Documents

Publication Publication Date Title
NO153177C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive tetrazolylalkoksy-karbostyrilderivater.
NO145199C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive nortropinestere.
NO770465L (no) Fremgangsm}te for fremstilling av fysiologisk aktive karboksyalkylacyl-aminosyrer.
NO770804L (no) Analogifremgangsm}te for fremstilling av terapeutisk aktive aminoalyl-heterocykliske forbindelser
NO822984L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive polypeptider.
NO773384L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-aryloksy-2-hydroksy-3-alkylenaminopropan-derivater
NO142034C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenoletere.
NO152899C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive glycerolderivater.
NO143219C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
NO780883L (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive 4-acylamino-fenyl-etanolaminer
NO770547L (no) Analogifremgangsm}te for fremstilling av farmakologisk aktive indolizinderivater.
NO141013C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive bifenylyl-derivater
NO802015L (no) Fremgangsmaate for fremstilling av fysiologisk aktive indolizin-derivater.
NO154841C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive karbo styrilderivater.
NO145792C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive pyrimidon-derivater
NO147986C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive fenyletylaminer
NO773327L (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive pyrazolopyridiner
NO149428C (no) Fremgangsmaate for fremstilling av fysiologisk aktive prostaglandinderivater.
NO151365C (no) Fremgangsmaate for fremstilling av 4-halogen-dihydropyran-derivater.
NO834363L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive sesquiterpenderivater
NO781878L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner.
NO772329L (no) Analogifremgangsm}te for fremstilling av terapeutisk aktive imidazolinderivater
NO772575L (no) Fremgangsm}te for fremstilling av farmas¦ytisk aktive preparater
NO147483C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive benzylpyrimidiner.
NO145950C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive homoftalimider